Enhance your practice with CME and tools that focus on the management of neurological conditions.
Updates in MS Care: Key Topics at AAN 2026
Aaron Miller, MD
The Social Brain in Schizophrenia
Shelina Ramnarine, PhD
Michael Green, PhD
Depression as a Signal of MS Progression
Advancing Pediatric MS Care: Insights from AAN 2026
Elizabeth Wilson, MD
Challenging the Status Quo in Schizophrenia Treatment
Stephen Marder, MD
Minimal By Design: Define MSE Endpoints
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Turning Flares Into Function: Flag Uncontrolled Disease
Shared Goals, Shared Gains: Align With Patient Preferences
When to Begin FcRn: Initiation Criteria, Key Evidence
The IgG Clock: Redose Using IgG Kinetics
The 2-Point Signal: Apply ≥2-Point Rule
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Addressing Social and Systemic Barriers in Schizophrenia
Margaret Emerson, DNP, APRN, PMHNP-BC
Emerging Serum microRNAs as Early Signals in MS
Family Planning in Patients with Multiple Sclerosis
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Escalate With Intention: Stepwise, Target-Anchored Moves
Strengthening Global Infrastructure for FSHD Trials
Marlene Mimi Maeusli, PhD.
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.